Stay updated on Pembrolizumab with REOLYSIN in Pancreatic Cancer Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab with REOLYSIN in Pancreatic Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab with REOLYSIN in Pancreatic Cancer Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    Added Revision: v3.4.2; removed the prior Revision: v3.4.1 and the government funding status notice.
    Difference
    0.4%
    Check dated 2026-02-11T01:40:04.000Z thumbnail image
  2. Check
    13 days ago
    Change Detected
    Summary
    A system-wide notice about a lapse in government funding was added and the site revision was updated from v3.4.0 to v3.4.1.
    Difference
    0.5%
    Check dated 2026-02-03T22:17:53.000Z thumbnail image
  3. Check
    20 days ago
    Change Detected
    Summary
    Adds a glossary toggle and a new QC label 'Last Update Submitted that Met QC Criteria', and updates FEAR Act text plus version to v3.4.0 while removing the older QC label and older FEAR Act wording. These are UI/metadata updates and do not change the core study content.
    Difference
    0.2%
    Check dated 2026-01-27T17:28:49.000Z thumbnail image
  4. Check
    28 days ago
    Change Detected
    Summary
    Revision updated from v3.3.3 to v3.3.4. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-20T15:40:36.000Z thumbnail image
  5. Check
    56 days ago
    Change Detected
    Summary
    Added a Locations section listing Texas as a study site and removed the separate Texas Locations footer entry; the HHS Vulnerability Disclosure link and the prior revision note were also removed.
    Difference
    0.2%
    Check dated 2025-12-22T23:48:53.000Z thumbnail image
  6. Check
    78 days ago
    Change Detected
    Summary
    Footer revision label updated from v3.3.1 to v3.3.2; no changes to study content or data are observed.
    Difference
    0.1%
    Check dated 2025-12-01T10:51:55.000Z thumbnail image

Stay in the know with updates to Pembrolizumab with REOLYSIN in Pancreatic Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab with REOLYSIN in Pancreatic Cancer Clinical Trial page.